Report Description

The stem cell market is growing rapidly due to increasing regulatory approval. The benefits of the stem cell therapy are also attracting an increasing number of patients. Intensive R&D efforts and the increasing research investments on stem cells therapy are soon expected to improve the efficacy of stem cell treatment. The product submarkets for human and embryo stem cells are also expected to drive the growth of the overall stem cells market. However, the high cost of the therapy may affect market growth. This report will help stakeholders gain a better understanding of product pricing and regulatory framework governing market dynamics. The U.S. currently forms the most lucrative stem cells market, especially for areas such as stem cell bone marrow transplantation.

Scope of the report

The report categorizes the global stem cell market as follows:

• Products (adult stem cell, human embryonic stem cell, and other stem cell types)
• Services (stem cell banking, stem cell acquisition and testing, drug discovery and target identification, isolation/characterization services, and molecular biology )
• Technology (stem cell acquisition, stem cell production, cryopreservation, and expansion and subculture)
• Applications (regenerative medicine – neurological disorders, orthopedics, cancer, hematological disorders, myocardial infarction and cardiovascular diseases, injuries, diabetes, liver disorder, incontinence, and drug development)

What makes our reports unique?

1. We provide the longest market segmentation chain in the industry with our three-level market breakdown and our analysis of minimum 40 collectively exhaustive and mutually exclusive micro markets.
2. We provide 10% customization to ensure that our clients find the specific market intelligence they need.
3. Each report is about 150 pages, featuring 30+ market data tables, 30+ company profiles, and an analysis of 200 patents.
4. No single report by any other publisher provides market data for all market segments (i.e. products, services, applications, ingredients, and technology) covering the four geographies of North America, Europe, Asia Pacific, and ROW.
5. 15 pages of high level analysis identifying opportunities, best practices, entry strategies, benchmarking strategies, market positioning, product positioning, and competitive positioning.

Key questions answered

1. Which are the high-growth segments and how is the market segmented in terms of applications, products, services, ingredients, technologies, stakeholders?
2. What are market estimates and forecasts; which markets are doing well and which are not?
3. Where are the gaps and opportunities; what factors are driving market growth?
4. Which are the key playing fields and winning-edge imperatives?
5. What is the competitive landscape; who are the main players in each segment; what are their strategic directives, operational strengths, key selling products, and product pipelines? Who is doing what?

Powerful Research and analysis

The analysts working with MarketsandMarkets come from renowned publishers and market research firms globally, adding their expertise and domain understanding. We get the facts from over 22,000 news and information sources, a huge database of key industry participants and draw on our relationships with more than 900 market research companies.

Table of contents  

Executive summary  
   MARKET OVERVIEW  
   Stem cell market dynamics  
      OPPORTUNITIES  
   Stem cells product market  
      OPPORTUNITIES  
   Stem cells technology market  
   Stem cells services market  
   Stem cells applications market  
   Geographic analysis  
   Competitive landscape  

1. INTRODUCTION  
   1.1. KEY TAKE-AWAYS  
   1.2. REPORT DESCRIPTION  
   1.3. Research METHODOLOGY
   1.4. STAKEHOLDERS  

2. Summary  

3. market overview  
   3.1. Defining the stem cell market  
   3.2. Factors influencing the stem cells market  
   3.3. Stem cell market inhibitors  
   3.4. Regenerative medicine dominates stem cell applications  
   3.5. FACTORS INFLUENCING THE STEM CELLS MARKET  
        3.5.1. U.S. Liberal Politics  
        3.5.2. Guidelines for responsible stem cells research  
        3.5.3. European national policies and legal issues  
        3.5.4. E.U. funding for stem cells research  
        3.5.5. Asia Pacific  
   3.6. Stem cell patent analysis  

4. Stem cell market dynamics  
   4.1. Drivers  
        4.1.1. Potential of stem cells in regenerative medicine  
        4.1.2. Key to anti-ageing and prolonging life  
        4.1.3. Increasing R&D INVESTMENTS in adult stem cell research  
        4.1.4. EASE of administration  
        4.1.5. Reduced risk of tissue rejection in transplants  
        4.1.6. Federal funding for stem cell research  
   4.2. Restraints  
        4.2.1. safety issues  
        4.2.2. Ethical issueS  
        4.2.3. minimal Insurance coverage  
   4.3. Opportunities  
        4.3.1. technological innovations  
        4.3.2. Emerging application as a drug discovery tool  
        4.3.3. other promising applications  

5. Global stem cells product market  
   5.1. Stem cell classification on the basis of potency  
   5.2. Adult stem cells  
        5.2.1. Drivers  
               5.2.1.1. Applications in cancer and chronic disease treatment  
               5.2.1.2. Availability of adequate safety & efficacy evidence  
               5.2.1.3. Technology innovations  
               5.2.1.4. Lower costs & no ethical issues  
        5.2.2. Restraints & Opportunities  
               5.2.2.1. Lower therapeutic potential  
               5.2.2.2. Need for minimising intervention  
        5.2.3. Hematopoietic Stem Cells  
               5.2.3.1. Drivers & Restraints  
                        5.2.3.1.1. Wide range of applications  
                        5.2.3.1.2. Enhanced usage due to recent technology advancements  
                        5.2.3.1.3. Underused treatment, ineffective GvHD management  
        5.2.4. Mesenchymal stem cells  
               5.2.4.1. Drivers  
                        5.2.4.1.1. Huge potential of MSCs  
                        5.2.4.1.2. Advantageous cell type for allogenic transplantation  
               5.2.4.2. Restraints & Opportunities  
                        5.2.4.2.1. Low number of mesenchymal stem cells in bone marrow  
               5.2.4.3. Potential applications of MSC therapy  
   5.3. Embryonic stem cells  
        5.3.1. Drivers & REStraints  
               5.3.1.1. Immense potential due to pluripotent nature  
               5.3.1.2. Ban on federal funding lifted  
               5.3.1.3. Ethical issues and inadequate safety data  
        5.3.2. Umbilical cord stem cells  
        5.3.3. Neuronal stem cells  
        5.3.4. Dental stem cells  
        5.3.5. Other novel cell types  

6. stem cells technology market  
   6.1. Stem cell production  
        6.1.1. Somatic nuclear transfer / Therapeutic cloning  
        6.1.2. IVF (In vitro fertilization)  
        6.1.3. Isolation & Cell culture  
   6.2. Expansion & Sub culture  
   6.3. Stem cell acquisition  
        6.3.1. Bone marrow harvest  
        6.3.2. Apheresis  
        6.3.3. Umbilical cord blood stem cells acquisition  
   6.4. Cryopreservation & storage  

7. Global stem cells services market  
   7.1. Stem cell banking  
        7.1.1. Ethical issues on stem cell banking  
   7.2. Stem cell acquisition & testing  
   7.3. Characterization services  
        7.3.1. HLA typing services  
        7.3.2. Stem cell custom services  
        7.3.3. Stem cell custom antibody services  
   7.4. Molecular biology  
   7.5. Drug screening & target validation  

8. Global stem cells applications market  
   8.1. Regenerative medicine  
        8.1.1. Drivers & Restraints  
               8.1.1.1. Simple and cost-effective production method  
               8.1.1.2. Public & political support  
               8.1.1.3. High cost of treatment and low reimbursements  
        8.1.2. Neurological disorders  
               8.1.2.1. Alzheimer’s disease  
               8.1.2.2. Parkinson’s disease  
               8.1.2.3. Multiple sclerosis  
               8.1.2.4. Others  
        8.1.3. Myocardial Infarction & cardiovascular diseases  
        8.1.4. Cancer  
               8.1.4.1. Breast cancer  
               8.1.4.2. Multiple myeloma  
               8.1.4.3. Other diseases  
        8.1.5. Injuries  
        8.1.6. Incontinence  
        8.1.7. Diabetes  
        8.1.8. Orthopedics  
        8.1.9. Liver disorders  
        8.1.10. Hematological disorders  
                8.1.10.1. Other applications  
                          8.1.10.1.1. Limb Ischemia  
                          8.1.10.1.2. Systemic lupus  
   8.2. Drug Discovery & Development  

9. Geographic analysis  
   9.1. North America  
   9.2. Europe  
   9.3. Asia  
   9.4. ROW  

10. Competitive landscape  
Appendix  
    10.1. Government policies & guidelines  
          10.1.1. Patents for united states  
          10.1.2. Patents for europe  
          10.1.3. Patents for Japan  

11. Company Profiles  
    11.1. Advanced Cell Technology Inc  
    11.2. Aldagen  
    11.3. Angel Biotechnology  
    11.4. Angioblast Systems Inc  
    11.5. Aastrom Biosciences Inc  
    11.6. Athersys  
    11.7. Bioheart Inc  
    11.8. Brainstorm Cell Therapeutics  
    11.9. California Stem Cell  
    11.10. Celgene Corporation  
    11.11. Cellartis AB  
    11.12. Cellerant Therapeutics  
    11.13. Cellular Dynamics International, Inc  
    11.14. Cellular Engineering Technologies  
    11.15. CordLife Ltd  
    11.16. Cytori Therapeutics Inc  
    11.17. ES Cell International  
    11.18. Gamida Cell Ltd  
    11.19. Genzyme Corporation  
    11.20. Geron Corporation Inc  
    11.21. Global Stem Inc  
    11.22. Intercytex (and its subsidiary Axordia)  
    11.23. Medistem Inc  
    11.24. Mesoblast Ltd  
    11.25. MultiCell Technologies, Inc  
    11.26. Neostem  
    11.27. Novocell Inc  
    11.28. NeuralStem Biopharmaceuticals, Ltd.  
    11.29. Opexa Therapeutics  
    11.30. Osiris Therapeutics, Inc  
    11.31. Plureon Corp  
    11.32. Pluristem Therapeutics  
    11.33. ReNeuron, Inc  
    11.34. StemCells, Inc  
    11.35. StemLifeLine  
    11.36. t2cure Gmbh  
    11.37. TheraVitae  
    11.38. Thermo Fisher Scientific Inc  
    11.39. Thermogenesis Corporation  
    11.40. VetCell Bioscience Ltd  
   
  List of TableS  
  
SUMMARY TABLE  Global stem cell market 2009-2014 ($ thousands) 
Table 1 Global stem cell market by product 2007-2014 ($ Millions) 
Table 2 Global adult stem cell market by product 2007-2014 ($ Millions) 
Table 3 Global other novel cell types market by product 2007-2014 ($ Millions)
Table 4 Global stem cell technology market 2007-2014 ($ Millions) 
Table 5 Global stem cell production market by product 2007-2014 ($ Millions) 
Table 6 Global stem cell acquisition market by product 2007-2014 ($ Millions) 
Table 7 Global stem cell services market by product 2007-2014 $ Millions) 
Table 8 Global characterization services market by product 2007-2014 ($ Millions) 
Table 9 Global stem cell applications market by product  2007-2014 ($ Thousands)
Table 10 Global stem cell applications market by geography 2007-2014 ($ Millions) 
Table 11 Global regenerative medicine market by product 2007-2014 ($ Millions) 
Table 12 Global regenerative medicine market by geography 2007-2014 ($ Millions) 
Table 13 Global neurological disorders market by geography  2007-2014 ($ Millions) 
Table 14 Global Myocardial Infarction & cardiovascular diseases market by geography 2007-2014 ($ Millions) 
Table 15 Global cancer market by geography 2007-2014 ($ Millions) 
Table 16 Global Injuries market for stem cells by product 2007-2014 ($ Millions) 
Table 17 Global Injuries market for stem cells by geography  2007-2014 ($ Millions) 
Table 18 Global Incontinence market for stem cells by geography 2007-2014 ($ Millions) 
Table 19 Global Diabetes  market by geography 2007-2014 ($ Millions) 
Table 20 Global Orthopedics market in stem cells by geography 2007-2014 ($ Millions) 
Table 21 Global Liver disorders market by geography 2007-2014 ($ Millions) 
Table 22 Global Hematological disorders market by geography 2007-2014 ($ Millions) 
Table 23 Global Other regenerative medicines market by geography 2007-2014 ($ Millions) 
Table 24 Global Drug Discovery & Development market by geography 2007-2014 ($ Millions) 
Table 28 New product, technology, service launch (2008-2009) 
Table 29 List of agreements and collaborations (2008-2009) 
Table 30 List of mergers and acquisition (2008-2009) 
 
List of FIGURES  
  
Figure 1 STEM CELL MARKET SEGMENTATION 
Figure 2 Driving factors 
Figure 3 Inhibitor matrix 
Figure 4 Stem cell application market dynamics 
Figure 5 RELATIVE IMPORTANCE OF FACTORS AFFECTING STEM CELL MARKET 
Figure 6 NIH funding for stem cell research 
Figure 7 patent analysis by geography 2006 to 2008 
Figure 8 Patent analysis by segment 2006 to 2008 
Figure 9 Patent analysis by competitors 
Figure 10 Major market growth factors 
Figure 11 Stem cell classification on the basis of potency 
Figure 12 Stem cell technologies 
Figure 13 Prominent focus areas in regenerative medicine 
Figure 14 Stem cell transplants types 
Figure 15 global Stem cells market by geography ($billion) 
Figure 16 North American Stem cells market 
Figure 17 european Stem cells market 
Figure 18 asian Stem cells market 
Figure 19 row Stem cells market 
Figure 20 Major segments focused by global stem cell market players (2008-2009) 
figure 21 Competitive landscape for collaborations (2008-2009) 

Global Stem Cell and Advanced Technologies Market

The stem cell market is growing rapidly due to increasing regulatory approval and public acceptance bodies. The benefits of stem cell therapy are attracting an increasing number of patients. The product submarket for human and embryo stem cells are expected to drive the growth of the overall market. In addition, intensive R&D efforts and the increasing investments into research on stem cells therapy are soon expected to improve the efficacy of stem cell treatment. However, the high cost of the therapy may affect market growth.

The global stem cell market is estimated to be $88.3 billion by 2014, growing at a CAGR of 14.8 % from 2009 to 2014. The U.S. currently holds a 60% share of the global stem cell market; and forms an especially lucrative market for areas such as bone marrow transplantation through stem cells. This research report will help stakeholders gain a better understanding of product pricing and regulatory framework governing the dynamics of the stem cell market. The key players in the market include Osiris Therapeutics, Stem Tronix Inc., Stemcell Technologies, Genzyme Corp., Cytori, and Geron.

Estimated size of stem cell market in 2009

Please fill in the form below to receive a sample copy of the report.

* First Name :
* Last Name :
* Email :
* Job Title :
* Company :
* Phone: (Pls. Affix Country Code)
* Country:
* Area Code:
* Report name for which Sample is    needed :
* Do you have any Specific field of Interest? (Our USP is "Customised multi client reports"-so feel free to provide us specific interest in much greater detail..!!)
* Enter the text from the image    to the following textbox :	Phonetic spelling (mp3)

Custom Research

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit http://www.marketsandmarkets.com/custom-research.asp to specify your custom Research Requirement